Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: the CLEOPATRA trial - Combs, S E; Kieser, M; Rieken, S (BMC Cancer, 2010)
et al.